These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed by the Registrant
|
x
|
|
Filed by a Party other than the Registrant
|
¨
|
|
o
|
|
Preliminary Proxy Statement
|
|
o
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
x
|
|
Definitive Proxy Statement
|
|
o
|
|
Definitive Additional Materials
|
|
o
|
|
Soliciting Material Pursuant to §240.14a-11(c) or §240.14a-12
|
|
x
|
|
No fee required.
|
||
|
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
||
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
(5)
|
|
Total fee paid:
|
|
o
|
|
Fee paid previously with preliminary materials.
|
||
|
o
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
||
|
|
|
(1)
|
|
Amount Previously Paid:
|
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
(3)
|
|
Filing Party:
|
|
|
|
(4)
|
|
Date Filed:
|
|
|
||||
|
|
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON JUNE 18, 2019. THIS PROXY STATEMENT AND THE ANNUAL REPORT ARE AVAILABLE AT
HTTP://WWW.ASTPROXYPORTAL.COM/AST/21117/
|
|
|
|
|
|
|
|
PAGE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
By Internet
. You may submit a proxy electronically via the internet by following the instructions provided on the Notice of Internet Availability of Proxy Materials. Internet voting facilities will close and no longer be available on the date and time specified in the Notice of Internet Availability of Proxy Materials.
|
|
•
|
By Telephone
. You may submit a proxy by telephone using the toll-free number listed on the Notice of Internet Availability of Proxy Materials. Please have the notice or proxy card in hand when you call. Telephone voting facilities will close and no longer be available on the date and time specified in the Notice of Internet Availability of Proxy Materials.
|
|
•
|
By Mail
. If you received or requested printed proxy materials, you may submit a proxy by signing, dating and returning your proxy card in the provided pre-addressed envelope in accordance with the enclosed instructions. We encourage you to sign and return the proxy or voter instruction card even if you plan to attend the Annual Meeting. In this way, your shares will be voted even if you are unable to attend.
|
|
•
|
In Person
. If you plan to attend the Annual Meeting and vote in person, we will provide you with a ballot at the Annual Meeting. You may vote in person at the Annual Meeting by completing a ballot; however, attending the Annual Meeting without completing a ballot will not count as a vote.
|
|
•
|
Directors will be elected by a plurality of all votes cast. You may vote “FOR ALL NOMINEES,” “WITHHOLD AUTHORITY FOR ALL NOMINEES” or “FOR ALL EXCEPT” for the director nominees. Withheld votes and broker non-votes will have no effect on Proposal No. 1.
|
|
•
|
Ratification of the selection of Grant Thornton LLP as our independent registered public accounting firm will require the affirmative vote of a majority of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote on this matter. You may vote “FOR,” “AGAINST” or “ABSTAIN” on the proposal to ratify the selection of Grant Thornton LLP as our independent registered public accounting firm. Abstentions and broker non-votes will have the same effect as a vote against Proposal No. 2.
|
|
•
|
Approval, on an advisory basis, of the compensation of our named executive officers will require the affirmative vote of a majority of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote on this matter. You may vote “FOR,” “AGAINST” or “ABSTAIN” on the proposal to approve, on an advisory basis, the compensation of our named
|
|
•
|
FOR the election of the two persons named in this proxy statement as the board's nominees for election as Class III directors;
|
|
•
|
FOR the ratification of the selection of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2019; and
|
|
•
|
FOR the approval, on an advisory basis, of the compensation of our named executive officers.
|
|
Beneficial Owner
(1)
|
|
|
Number of shares
|
|
Percent of
class
|
||
|
Clearlake Capital Partners II (Master), L.P.
(2)
|
|
|
10,849,015
|
|
|
|
26.5%
|
|
Keystone Cranberry, LLC
(3)
|
|
|
5,842,700
|
|
|
|
14.3%
|
|
Clearbridge Investments, LLC
(4)
620 8th Avenue
New York, NY 10018
|
|
|
2,570,618
|
|
|
|
6.3%
|
|
FMR, LLC
(5)
245 Summer Street
Boston, MA 02210
|
|
|
2,628,856
|
|
|
|
6.4%
|
|
|
|
|
|
|
|
|
|
|
Directors/Named Executive Officers
|
|
|
|
|
|
|
|
|
Charles E. Young
|
|
|
6,242,362
|
|
(6)
|
|
15.2%
|
|
Lee Beckelman
|
|
|
236,176
|
|
(7)
|
|
*
|
|
Robert Kiszka
|
|
|
618,047
|
|
(8)
|
|
1.5%
|
|
José E. Feliciano
|
|
|
10,849,015
|
|
(9)
|
|
26.5%
|
|
Colin Leonard
|
|
|
13,962
|
|
(10)
|
|
*
|
|
Timothy J. Pawlenty
|
|
|
46,934
|
|
|
|
*
|
|
Andrew Speaker
|
|
|
1,167,267
|
|
|
|
2.8%
|
|
Sharon Spurlin
|
|
|
38,293
|
|
|
|
*
|
|
Tracy Robinson
|
|
|
40,959
|
|
|
|
*
|
|
William John Young
|
|
|
166,540
|
|
(11)
|
|
*
|
|
James D. Young
|
|
|
77,041
|
|
(12)
|
|
*
|
|
Ronald P. Whelan
|
|
|
81,616
|
|
(13)
|
|
*
|
|
Susan Neumann
|
|
|
39,522
|
|
(14)
|
|
*
|
|
All officers and directors as a group (13 persons)
|
|
|
19,603,772
|
|
(15)
|
|
47.8%
|
|
*
|
Represents less than one percent.
|
|
(1)
|
Unless otherwise indicated, the address for all beneficial owners in this table is c/o Smart Sand, Inc., 1725 Hughes Landing Boulevard, Suite 800, The Woodlands, Texas 77380.
|
|
(2)
|
Includes 27,924 shares held of record by José E. Feliciano and Colin Leonard for the benefit of Clearlake Capital Partners II (Master), L.P., a Delaware limited partnership ("CCPII" or "Clearlake"), which shares remain subject to vesting. Other than the foregoing, the shares are held of record by CCPII. CCPII is managed by Clearlake Capital Management II, L.P., a Delaware limited partnership (“CCMII”). CCMII’s general partner is Clearlake Capital Group, L.P., whose general partner is CCG Operations, L.L.C., a Delaware limited liability company (“CCG Ops”). CCPII’s general partner is Clearlake Capital Partners II GP, L.P., a Delaware limited partnership (“CCPII GP”). CCPII GP’s general partner is Clearlake Capital Partners, LLC, a Delaware limited liability company (“CCP”). CCP’s managing member is CCG Ops. José E. Feliciano and Behdad Eghbali are managers of CCG Ops and may be deemed to share voting and investment power of the shares held of record by CCPII. The address of Messrs. Feliciano and Eghbali and the entities named in this footnote is c/o Clearlake Capital Group, 233 Wilshire Blvd., Suite 800, Santa Monica, California 90401.
|
|
(3)
|
Charles E. Young owns approximately 67% of the membership interests in Keystone Cranberry, LLC, a Pennsylvania limited liability company (“Keystone Cranberry”), is the sole managing member and has sole voting and investment power over the shares held by Keystone Cranberry.
|
|
(4)
|
Based on a Schedule 13G/A filed with the SEC on February 14, 2019, by Clearbridge Investments, LLC. As of December 31, 2018, Clearbridge Investments is the beneficial owner of 2,570,618 shares over which it has sole investment power. Clearbridge Investments has sole voting power with respect to 2,271,838 shares.
|
|
(5)
|
Based on a Schedule 13G/A filed with the SEC on February 13, 2019, by FMR, LLC. As of December 31, 2018, FMR is the beneficial owner of 2,628,856 shares over which it has sole investment power. FMR has sole voting power with respect to 56,362 shares. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR, LLC and may be deemed to beneficially own 2,628,856 shares.
|
|
(6)
|
Includes 180,436 shares of common stock that remain subject to vesting, of which 108,906 shares vest based upon the achievement of certain performance metrics. Other than 335,586 shares owned directly by Mr. Young, all shares are held of record by Keystone Cranberry. Mr. Young owns approximately 67% of the membership interests in Keystone Cranberry, is the sole managing member and has sole voting and investment power over the shares held by Keystone Cranberry. Also includes 36,850 shares of restricted stock issued under the 2012 Plan as the holders of such shares of restricted stock have executed a proxy in favor of Mr. Young.
|
|
(7)
|
Includes 102,914 shares of common stock that remain subject to vesting, of which 57,379 shares vest upon the achievement of certain performance metrics.
|
|
(8)
|
Includes 77,357 shares of common stock that remain subject to vesting, of which 43,718 shares vest upon the achievement of certain performance metrics. Other than 149,273 shares held directly by Mr. Kiszka, all shares are held of record by BAMK Associates, LLC, a Pennsylvania limited liability company. Mr. Kiszka is the sole member and has sole voting and investment power over the shares held by BAMK Associates, LLC.
|
|
(9)
|
Includes 13,962 shares held of record by Mr. Feliciano for the benefit of CCPII, which shares remain subject to vesting. As further described in footnote (2) above, Mr. Feliciano may be deemed to share voting and investment power of the shares held of record by CCPII. The address of Mr. Feliciano is c/o Clearlake Capital Group, 233 Wilshire Blvd., Suite 800, Santa Monica, California 90401.
|
|
(10)
|
Consists of shares held of record by Mr. Leonard for the benefit of CCPII, which shares remain subject to vesting. The address of Mr. Leonard is c/o Clearlake Capital Group, 233 Wilshire Blvd., Suite 800, Santa Monica, California 90401.
|
|
(11)
|
Includes 96,683 shares of common stock that remain subject to vesting, of which 53,225 shares vest upon the achievement of certain performance metrics.
|
|
(12)
|
Includes 59,813 shares of common stock that remain subject to vesting, of which 27,322 shares vest upon the achievement of certain performance metrics.
|
|
(13)
|
Includes 49,244 shares of common stock that remain subject to vesting, of which 26,563 shares vest upon the achievement of certain performance metrics.
|
|
(14)
|
Includes 18,528 shares of common stock that remain subject to vesting, of which 3,552 shares vest upon the achievement of certain performance metrics.
|
|
(15)
|
Does not include 13,962 shares beneficially owned by Mr. Leonard as such shares are also beneficially owned by Mr. Feliciano and including them would be duplicative.
|
|
Nominees
|
|
Class
|
|
Age
|
|
Position
|
|
Year
Appointed
|
|
Term
Expiration
|
|
Expiration of Term for
Which Nominated
|
|
Charles E. Young
|
|
III
|
|
51
|
|
Chief Executive
Officer and Director
|
|
2011
|
|
2019
|
|
2022
|
|
José E. Feliciano
(1)
|
|
III
|
|
45
|
|
Co-Chairman of the
Board
|
|
2011
|
|
2019
|
|
2022
|
|
Continuing Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Timothy J. Pawlenty
(2)
|
|
I
|
|
58
|
|
Director
|
|
2012
|
|
2020
|
|
|
|
Sharon S. Spurlin
(3)
|
|
I
|
|
54
|
|
Director
|
|
2015
|
|
2020
|
|
|
|
Colin M. Leonard
(4)
|
|
II
|
|
37
|
|
Director
|
|
2011
|
|
2018
|
|
|
|
Andrew Speaker
|
|
II
|
|
56
|
|
Co-Chairman of the
Board
|
|
2011
|
|
2018
|
|
|
|
Not Standing for Re-Election
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tracy Robinson
(5)
|
|
III
|
|
55
|
|
Director
|
|
2015
|
|
2019
|
|
|
|
(1)
|
Chairperson of the compensation committee
|
|
(2)
|
Member of audit committee and compensation committee
|
|
(3)
|
Chairperson of audit committee
|
|
(4)
|
Chairperson of nominating and corporate governance committee
|
|
(5)
|
Member of audit committee, compensation committee and nominating and corporate governance committee
|
|
Name
|
Age
|
Position
|
|
Lee E. Beckelman
|
53
|
Chief Financial Officer
|
|
William John Young
|
45
|
Chief Operating Officer
|
|
Robert Kiszka
|
51
|
Executive Vice President of Operations
|
|
Ronald P. Whelan
|
42
|
Executive Vice President of Sales
|
|
James D. Young
|
39
|
Executive Vice President, General Counsel and Secretary
|
|
Susan Neumann
|
40
|
Vice President of Accounting and Controller
|
|
•
|
any increase or decrease in the size or composition of the board of directors, any committees of the board of directors, or any board or board committee of any subsidiary of the Company; or
|
|
•
|
any action that otherwise could reasonably be expected to adversely affect such Principal Stockholder’s board of directors and committee designation rights.
|
|
•
|
Charles E. Young, Chief Executive Officer;
|
|
•
|
Lee E. Beckelman, Chief Financial Officer; and
|
|
•
|
William John Young, Chief Operating Officer.
|
|
Name and principal position
|
|
Year
|
|
|
Salary ($)
|
|
Bonus ($)
(1)
|
|
Stock
Awards ($)
(2)
|
|
All other
Compensation ($)
|
|
Total ($)
|
||||||||||||
|
Charles E. Young
|
|
2018
|
|
|
$
|
512,308
|
|
|
$
|
140,884
|
|
(3)
|
$
|
959,016
|
|
|
$
|
55,974
|
|
(4)
|
|
$
|
1,668,182
|
|
|
|
|
Chief Executive Officer
|
|
2017
|
|
|
$
|
500,000
|
|
|
$
|
250,000
|
|
|
$
|
1,296,764
|
|
|
$
|
71,368
|
|
(5)
|
|
$
|
2,118,132
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Lee E. Beckelman
|
|
2018
|
|
|
$
|
388,269
|
|
|
$
|
106,804
|
|
(6)
|
$
|
575,402
|
|
|
$
|
19,802
|
|
(7)
|
|
$
|
1,090,277
|
|
|
|
|
Chief Financial Officer
|
|
2017
|
|
|
$
|
354,808
|
|
|
$
|
195,144
|
|
|
$
|
665,710
|
|
|
$
|
25,519
|
|
(7)
|
|
$
|
1,241,181
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
William John Young
(8)
|
|
2018
|
|
|
$
|
310,154
|
|
|
$
|
85,293
|
|
(9)
|
$
|
575,402
|
|
|
$
|
19,258
|
|
(10)
|
|
$
|
990,107
|
|
|
|
|
Chief Operating Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
(1)
|
Amounts shown represent awards paid under our annual bonus plan for 2018 as determined by the compensation committee.
|
|
(2)
|
Represents the grant date fair value of restricted stock awards granted in 2018 computed in accordance with FASB ASC 718.
|
|
(3)
|
Amount shown does not include $140,885 awarded by the compensation committee and to be paid in 2019, which amounts are subject to forfeiture in management's discretion.
|
|
(4)
|
Amount shown represents costs associated with providing Mr. Young use of a Company-owned automobile ($6,817), country club membership dues ($28,282), employer contributions made under our 401(k) Plan ($20,375) and an employee referral award ($500).
|
|
(5)
|
Amount shown represents costs associated with providing Mr. Young use of a Company-owned automobile ($6,832), country club membership dues ($28,668), and employer contributions made under our 401(k) Plan ($35,868).
|
|
(6)
|
Amount shown does not include $106,744 awarded by the compensation committee and to be paid in 2019, which amounts are subject to forfeiture in management's discretion.
|
|
(7)
|
Amounts shown represents Mr. Beckelman’s employer contributions made under our 401(k) Plan.
|
|
(8)
|
Mr. Young was not a named executive officer during the year ended December 31, 2017 and therefore his compensation for 2017 has been omitted.
|
|
(9)
|
Amount shown does not include $85,292 awarded by the compensation committee and paid in 2019, which amounts were subject to forfeiture in management's discretion.
|
|
(10)
|
Amounts shown represents costs associated with providing Mr. Young use of a Company-owned automobile ($3,439) and employer contributions made under our 401(k) Plan ($15,819).
|
|
Name
|
|
Number of shares that have not vested (#)
|
|
|
Market value of shares
that have not vested ($)
(4)
|
|
Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested (#)
|
|
|
Equity incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested ($)
(4)
|
||||
|
Charles E. Young
|
|
98,756
|
(1)
|
|
$
|
219,238
|
|
|
108,906
|
(5)
|
|
$
|
241,771
|
|
|
Lee E. Beckelman
|
|
59,880
|
(2)
|
|
$
|
132,934
|
|
|
57,379
|
(6)
|
|
$
|
127,381
|
|
|
William John Young
|
|
72,164
|
(3)
|
|
$
|
160,204
|
|
|
53,225
|
(7)
|
|
$
|
118,160
|
|
|
(1)
|
Consists of: (i) 30,450 restricted shares that vest in equal annual installments on each of March 30, 2019, 2020 and 2021; and (ii) 68,306 restricted shares that vest in equal annual installments on each of April 30, 2019, 2020, 2021 and 2022. The foregoing is subject to Mr. Young’s continued employment on each applicable vesting date.
|
|
(2)
|
Consists of: (i) 6,600 restricted shares that vest on March 15, 2020; (ii) 12,297 restricted shares that vest in equal annual installments on each of March 30, 2019, 2020 and 2021; and (iii) 40,983 restricted shares that vest in equal annual installments on each of April 30, 2019, 2020, 2021 and 2022. All of the foregoing are subject to Mr. Beckelman’s continued employment on each applicable vesting date.
|
|
(3)
|
Consists of: (i) 15,400 restricted shares that vest on June 10, 2019; (ii) 6,600 restricted shares that vest on March 15, 2020; (iii) 9,182 restricted shares that vest in equal annual installments on each of March 30, 2019, 2020 and 2021; and (iv) 40,983 restricted shares that vest in equal annual installments on each of April 30, 2019, 2020, 2021 and 2022. All of the foregoing are subject to Mr. Young’s continued employment on each applicable vesting date.
|
|
(4)
|
Amount shown is based on the closing price of our common stock on December 31, 2018 of $2.22 per share.
|
|
(5)
|
Consists of (i) 40,600 restricted shares that vest based on the achievement of certain company performance conditions through December 31, 2019, and (ii) 68,306 restricted shares that vest based on the achievement of certain company performance conditions through December 31, 2020. The foregoing is subject to Mr. Young’s continued employment on the applicable vesting date.
|
|
(6)
|
Consists of: (i) 16,396 restricted shares that vest based on the achievement of certain company performance conditions through December 31, 2019; and (ii) 40,983 restricted shares that vest based on the achievement of certain company performance conditions through December 31, 2020. All of the foregoing are subject to Mr. Beckelman’s continued employment on each applicable vesting date.
|
|
(7)
|
Consists of: (i) 12,242 restricted shares that vest based on the achievement of certain company performance conditions through December 31, 2019; and (ii) 40,983 restricted shares that vest based on the achievement of certain company performance conditions through December 31, 2020. All of the foregoing are subject to Mr. Young’s continued employment on each applicable vesting date.
|
|
Name
|
|
Fees earned or
paid in cash ($)
|
|
Stock awards ($)
(1)
|
|
Total ($)
|
||||||
|
José E. Feliciano
(2)
|
|
$
|
112,500
|
|
|
$
|
80,002
|
|
|
$
|
192,502
|
|
|
Colin M. Leonard
(2)
|
|
$
|
72,500
|
|
|
$
|
80,002
|
|
|
$
|
152,502
|
|
|
Timothy J. Pawlenty
|
|
$
|
60,000
|
|
|
$
|
80,002
|
|
|
$
|
140,002
|
|
|
Tracy Robinson
|
|
$
|
60,000
|
|
|
$
|
80,002
|
|
|
$
|
140,002
|
|
|
Sharon Spurlin
|
|
$
|
72,500
|
|
|
$
|
80,002
|
|
|
$
|
152,502
|
|
|
Andrew Speaker
(3)
|
|
$
|
—
|
|
|
$
|
80,002
|
|
|
$
|
80,002
|
|
|
(1)
|
Directors were each granted 13,962 restricted shares that vest on June 11, 2019.
|
|
(2)
|
These directors are employed by Clearlake and, pursuant to arrangements with Clearlake, amounts shown are either paid to Clearlake at the direction of the directors or, in the case of stock awards, subsequently transferred to Clearlake after vesting.
|
|
(3)
|
Mr. Speaker is also an employee of the Company and holds the position of Senior Advisor on Special Projects. We paid Mr. Speaker cash compensation of $100,001 and a 401(k) contribution of $3,969 in 2018 in connection with his employment.
|
|
|
|
Number of common shares to be issued upon exercise of outstanding options, warrants and rights
(a)
|
|
Weighted-average exercise price of outstanding option, warrants and rights
(b)
|
|
Number of common shares remaining available for future issuance under equity compensation plans (excluding shares reflected in column (a))
(c)
|
|||||
|
Equity compensation plans approved by security holders
(1)
|
|
—
|
|
|
$
|
—
|
|
|
6,967,845
|
|
(2)
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
|
Total
|
|
—
|
|
|
$
|
—
|
|
|
6,967,845
|
|
|
|
(1)
|
Includes information regarding the 2012 Plan, the 2016 Plan and the 2016 Employee Stock Purchase Plan (the “2016 ESPP”).
|
|
(2)
|
Represents 267,850 shares available for issuance under the 2012 Plan, 2,810,503 shares available for issuance under the 2016 Plan and 3,889,492 shares available for issuance under the 2016 ESPP. To the extent outstanding awards under the 2012 Plan are forfeited or lapse unexercised, the shares of common stock subject to such awards will become available for issuance under the 2016 Plan. As of December 31, 2018, there were 78,650 unvested restricted shares outstanding under the 2012 Plan and 947,939 unvested restricted shares outstanding under the 2016 Plan. Purchase rights for 20,954 shares of common stock were outstanding under the 2016 ESPP as of December 31, 2018.
|
|
|
|
Year Ended December 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Audit fees
|
|
$
|
512,441
|
|
|
$
|
406,205
|
|
|
Audit-related fees
|
|
—
|
|
|
—
|
|
||
|
Tax fees
|
|
—
|
|
|
—
|
|
||
|
All other fees
|
|
—
|
|
|
—
|
|
||
|
|
|
$
|
512,441
|
|
|
$
|
460,205
|
|
|
The board of directors recommends a vote FOR the proposal to ratify the selection of Grant Thornton as our independent registered public accounting firm for the fiscal year ending December 31, 2019.
|
|
The board of directors recommends an advisory vote FOR the resolution to approve the compensation of the named executive officers as disclosed in this proxy statement.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|